[go: up one dir, main page]

FI951514A - Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita - Google Patents

Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita Download PDF

Info

Publication number
FI951514A
FI951514A FI951514A FI951514A FI951514A FI 951514 A FI951514 A FI 951514A FI 951514 A FI951514 A FI 951514A FI 951514 A FI951514 A FI 951514A FI 951514 A FI951514 A FI 951514A
Authority
FI
Finland
Prior art keywords
dna gyrase
gyrase inhibitors
new mono
bicyclic dna
bicyclic
Prior art date
Application number
FI951514A
Other languages
English (en)
Swedish (sv)
Other versions
FI951514A0 (fi
Inventor
Juergen Geiwiz
Erwin Goetschi
Paul Heibeisen
Helmut Link
Thomas Luebbers
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI951514A0 publication Critical patent/FI951514A0/fi
Publication of FI951514A publication Critical patent/FI951514A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D291/00Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI951514A 1994-03-30 1995-03-30 Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita FI951514A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94104995 1994-03-30
EP95101595 1995-02-07

Publications (2)

Publication Number Publication Date
FI951514A0 FI951514A0 (fi) 1995-03-30
FI951514A true FI951514A (fi) 1995-10-01

Family

ID=26135552

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951514A FI951514A (fi) 1994-03-30 1995-03-30 Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita

Country Status (15)

Country Link
US (3) US5589473A (fi)
EP (1) EP0675122A3 (fi)
JP (1) JP2695132B2 (fi)
KR (1) KR950032185A (fi)
CN (2) CN1114648A (fi)
AU (1) AU694936B2 (fi)
CA (1) CA2144499A1 (fi)
CZ (1) CZ78895A3 (fi)
FI (1) FI951514A (fi)
HU (1) HUT72491A (fi)
IL (1) IL113123A (fi)
NO (1) NO304024B1 (fi)
NZ (1) NZ270801A (fi)
RU (1) RU95104899A (fi)
TW (1) TW343965B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5922883A (en) * 1996-04-03 1999-07-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP4851933B2 (ja) 2003-04-11 2012-01-11 ピーティーシー セラピューティクス,インコーポレーテッド 1,2,4−オキサジアゾール安息香酸化合物ならびにナンセンス抑制及び疾患の治療のためのその使用
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds
FR2866887A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
GB0500683D0 (en) 2005-01-13 2005-02-23 Novartis Ag Organic compounds
CA2594943A1 (en) * 2005-01-19 2006-07-27 Merck & Co., Inc. Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
CN101184487B (zh) * 2005-03-31 2010-11-03 詹森药业有限公司 作为抗菌剂的二环吡唑化合物
CA2647903C (en) 2006-03-30 2016-12-13 Ptc Therapeutics, Inc. Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
US7829709B1 (en) * 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
JP5796881B2 (ja) * 2008-02-07 2015-10-21 マーケット ユニバーシティー 統合失調症を治療するため及び薬物渇望を低減するためのシステイン及びシスチンプロドラッグ
WO2009137251A2 (en) * 2008-04-16 2009-11-12 Marquette University Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
WO2012021704A1 (en) 2010-08-12 2012-02-16 Enanta Pharmaceuticals, Inc. Hepatitis c virus inhibitors
KR101604119B1 (ko) * 2011-06-14 2016-03-16 주식회사 녹십자 신규한 c-아릴 안사 sglt2 억제제
RS57816B1 (sr) 2013-05-10 2018-12-31 Karus Therapeutics Ltd Inhibitori histon deacetilaze
WO2015134711A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
GB201419228D0 (en) * 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
MX2018005361A (es) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Metodos para tratar epilepsia.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018490A1 (en) * 1991-04-17 1992-10-29 F. Hoffmann-La Roche Ag Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same

Also Published As

Publication number Publication date
US5589473A (en) 1996-12-31
RU95104899A (ru) 1997-01-10
KR950032185A (ko) 1995-12-20
AU694936B2 (en) 1998-08-06
IL113123A (en) 1999-11-30
JPH07285953A (ja) 1995-10-31
CN1114648A (zh) 1996-01-10
CZ78895A3 (en) 1995-12-13
EP0675122A2 (en) 1995-10-04
CA2144499A1 (en) 1995-10-01
US5594135A (en) 1997-01-14
EP0675122A3 (en) 1997-11-05
US5665746A (en) 1997-09-09
NZ270801A (en) 1997-01-29
HUT72491A (en) 1996-05-28
NO951210L (no) 1995-10-02
JP2695132B2 (ja) 1997-12-24
CN1308071A (zh) 2001-08-15
TW343965B (en) 1998-11-01
IL113123A0 (en) 1995-06-29
FI951514A0 (fi) 1995-03-30
HU9500860D0 (en) 1995-05-29
NO951210D0 (no) 1995-03-29
NO304024B1 (no) 1998-10-12
AU1507095A (en) 1995-10-12

Similar Documents

Publication Publication Date Title
DE59510304D1 (de) Bohrfutter
DE19581725T1 (de) Spannfutter
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI951514A (fi) Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
DE69626758D1 (de) Werkstückdrehtisch
DE59510981D1 (de) Bohrfutter
DE69612854D1 (de) Spannfutter
DK0738150T3 (da) Bicykliske fibrinogene antagonister
DE69528980D1 (de) Bohrfutter
DE69724663D1 (de) Abstandshalter
FI954991A (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
DE69514175D1 (de) Spannfutter
DE69807529D1 (de) Werkstück halteblock
DE69408656D1 (de) Plättchen-Halter
DK0768151T3 (da) Værktøjsholder
DK0768150T3 (da) Værktøjsholder
NO970431D0 (no) Tetrahydroisokinolin-derivater
ZA952380B (en) Novel mono- and bicyclic DNA gyrase inhibitors
NO20000547D0 (no) Verktoey og fremgangsmåte for fremstilling av samme
KR960016133U (ko) 스프링이 설치된 비조버클
NO942127D0 (no) Underbenklær
FI1444U1 (fi) Chuck foer en formmaskin
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β